Frank Rösch

5.1k total citations
176 papers, 4.0k citations indexed

About

Frank Rösch is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Frank Rösch has authored 176 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Radiology, Nuclear Medicine and Imaging, 38 papers in Oncology and 37 papers in Molecular Biology. Recurrent topics in Frank Rösch's work include Radiopharmaceutical Chemistry and Applications (88 papers), Medical Imaging Techniques and Applications (56 papers) and Medical Imaging and Pathology Studies (21 papers). Frank Rösch is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (88 papers), Medical Imaging Techniques and Applications (56 papers) and Medical Imaging and Pathology Studies (21 papers). Frank Rösch collaborates with scholars based in Germany, United States and Russia. Frank Rösch's co-authors include Markus Piel, Ingo Vernaleken, S.M. Qaim, Oliver Thews, Ralf Schirrmacher, Hans‐Georg Buchholz, Natalia S. Loktionova, Elisabeth Eppard, Rudolf Zentel and A.F. Novgorodov and has published in prestigious journals such as SHILAP Revista de lepidopterología, NeuroImage and American Journal of Psychiatry.

In The Last Decade

Frank Rösch

173 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frank Rösch Germany	34	2.0k	792	767	665	406	176	4.0k
Takahiro Mukai Japan	33	1.9k 0.9×	722 0.9×	723 0.9×	1.1k 1.7×	336 0.8×	227	4.4k
Alfons Verbruggen Belgium	45	2.2k 1.1×	873 1.1×	861 1.1×	1.6k 2.3×	431 1.1×	261	5.2k
Jae Min Jeong South Korea	43	2.6k 1.3×	733 0.9×	1.1k 1.4×	1.6k 2.3×	208 0.5×	214	5.8k
Yearn Seong Choe South Korea	35	1.1k 0.6×	308 0.4×	519 0.7×	852 1.3×	255 0.6×	172	3.9k
Seung Jun Oh South Korea	36	1.4k 0.7×	394 0.5×	465 0.6×	1.1k 1.6×	240 0.6×	207	4.7k
Wolfgang Wadsak Austria	44	2.0k 1.0×	1.0k 1.3×	791 1.0×	908 1.4×	891 2.2×	264	5.9k
Yasuhisa Fujibayashi Japan	46	3.7k 1.8×	1.1k 1.4×	1.4k 1.9×	1.5k 2.2×	230 0.6×	237	7.3k
James R. Ballinger Canada	32	1.3k 0.6×	847 1.1×	488 0.6×	459 0.7×	247 0.6×	131	3.1k
Wynn A. Volkert United States	37	3.2k 1.6×	1.6k 2.0×	1.0k 1.4×	841 1.3×	272 0.7×	136	5.0k
Yun‐Sang Lee South Korea	32	1.3k 0.6×	413 0.5×	472 0.6×	957 1.4×	145 0.4×	166	3.4k

Countries citing papers authored by Frank Rösch

Since Specialization

Citations

This map shows the geographic impact of Frank Rösch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Rösch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Rösch more than expected).

Fields of papers citing papers by Frank Rösch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Rösch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Rösch. The network helps show where Frank Rösch may publish in the future.

Co-authorship network of co-authors of Frank Rösch

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Rösch. A scholar is included among the top collaborators of Frank Rösch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Rösch. Frank Rösch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Läppchen, Tilman, Euy Sung Moon, Dariusz Pawlak, et al.. (2025). A true theranostic pair – 44/47Sc-labeled GRPR antagonist shows great promise for managing prostate and breast cancer. European Journal of Nuclear Medicine and Molecular Imaging. 53(4). 2554–2565.

Gnesin, Silvano, et al.. (2025). Preclinical evaluation of DOTAGA.Glu.(FAPI)2 and DO3A.Glu.(FAPI)2 as theranostics with human dosimetry extrapolation to lutetium-177 and terbium-161 analogs. European Journal of Nuclear Medicine and Molecular Imaging. 53(3). 1887–1901. 1 indexed citations

Läppchen, Tilman, et al.. (2025). Preclinical Evaluation of a ¹⁷⁷ Lu-Labeled Gastrin-Releasing Peptide Receptor Antagonist and Prostate Cancer Treatment with Monotherapy and in Combination with Everolimus. ACS Pharmacology & Translational Science. 9(1). 59–68. 1 indexed citations

Läppchen, Tilman, Surachet Imlimthan, Euy Sung Moon, et al.. (2024). Tailoring Fibroblast-Activation Protein Targeting for Theranostics: A Comparative Preclinical Evaluation of the 68Ga- and 177Lu-Labeled Monomeric and Dimeric Fibroblast-Activation Protein Inhibitors DOTA.SA.FAPi and DOTAGA.(SA.FAPi)2. Molecules. 29(13). 3093–3093. 6 indexed citations

Kurth, Jens, Surachet Imlimthan, Euy Sung Moon, et al.. (2023). Translational assessment of a DATA-functionalized FAP inhibitor with facile 68Ga-labeling at room temperature. European Journal of Nuclear Medicine and Molecular Imaging. 50(11). 3202–3213. 7 indexed citations

Martin, Mike W., et al.. (2023). Radiolabeling of 3BP-3940 with 68Ga, 90Y, 177Lu and 225Ac for imaging and Peptide Targeted Radiotherapy (PTRT). Nuklearmedizin - NuclearMedicine. 62(2). 149–149. 1 indexed citations

Poulie, Christian B. M., Vladimir Shalgunov, Filipe Elvas, et al.. (2023). Next generation fibroblast activation protein (FAP) targeting PET tracers - The tetrazine ligation allows an easy and convenient way to 18F-labeled (4-quinolinoyl)glycyl-2-cyanopyrrolidines. European Journal of Medicinal Chemistry. 262. 115862–115862. 10 indexed citations

Zhang, Jian, et al.. (2023). First-in-human Study of an Optimized, Kit-type, SSTR Antagonist 68Ga-DATA5m-LM4 in Patients with Metastatic Neuroendocrine Tumors. Nuklearmedizin - NuclearMedicine. 62(2). 86–86. 1 indexed citations

Moon, Euy Sung, Ian Alberts, Ali Afshar‐Oromieh, et al.. (2020). Effect of the versatile bifunctional chelator AAZTA5 on the radiometal labelling properties and the in vitro performance of a gastrin releasing peptide receptor antagonist. EJNMMI Radiopharmacy and Chemistry. 5(1). 29–29. 11 indexed citations

10.

Lawal, Ismaheel O., Kgomotso Mokoala, Johncy Mahapane, et al.. (2020). A prospective intra-individual comparison of [68Ga]Ga-PSMA-11 PET/CT, [68Ga]Ga-NODAGAZOL PET/CT, and [99mTc]Tc-MDP bone scintigraphy for radionuclide imaging of prostate cancer skeletal metastases. European Journal of Nuclear Medicine and Molecular Imaging. 48(1). 134–142. 23 indexed citations

11.

Krämer, Stefan, et al.. (2017). Long-term biodistribution study of HPMA- ran -LMA copolymers in vivo by means of 131 I-labeling. Nuclear Medicine and Biology. 58. 59–66. 6 indexed citations

12.

Schieferstein, Hanno, Markus Piel, Hartmut Lüddens, et al.. (2014). Selective binding to monoamine oxidase A: In vitro and in vivo evaluation of 18F-labeled β-carboline derivatives. Bioorganic & Medicinal Chemistry. 23(3). 612–623. 15 indexed citations

13.

Baum, Richard P. & Frank Rösch. (2013). Theranostics, Gallium-68, and other radionuclides : a pathway to personalized diagnosis and treatment. DIAL (Catholic University of Leuven). 4 indexed citations

14.

Piel, Markus, Ulrich Schmitt, Nicole Bausbacher, et al.. (2013). Evaluation of P-glycoprotein (abcb1a/b) modulation of [18F]fallypride in MicroPET imaging studies. Neuropharmacology. 84. 152–158. 7 indexed citations

15.

Vértes, A., et al.. (2011). Elements and isotopes formation, transformation, distribution. Springer eBooks. 10 indexed citations

16.

Fellner, Marco, Wolfgang Dillenburg, Hans‐Georg Buchholz, et al.. (2010). Assessing p-Glycoprotein (Pgp) Activity In Vivo Utilizing 68Ga–Schiff Base Complexes. Molecular Imaging and Biology. 13(5). 985–994. 10 indexed citations

17.

Herth, Matthias M., et al.. (2009). Preliminary in vivo and ex vivo evaluation of the 5-HT2A imaging probe [18F]MH.MZ. Nuclear Medicine and Biology. 36(4). 447–454. 20 indexed citations

18.

Kaina, Bernd, Andrea Piée‐Staffa, Markus Christmann, et al.. (2004). Inhibition of O6-Methylguanine-DNA Methyltransferase by Glucose-Conjugated Inhibitors: Comparison with Nonconjugated Inhibitors and Effect on Fotemustine and Temozolomide-Induced Cell Death. Journal of Pharmacology and Experimental Therapeutics. 311(2). 585–593. 50 indexed citations

19.

Schirrmacher, Ralf, et al.. (2002). An approach to the evaluation of the activity of the DNA repair enzyme O6-methylguanine-DNA-methyl-transferase in tumor tissue in vivo: syntheses of 6-benzyloxy-9-(2-[18F]fluoroethyl)-9H-purin-2-yl-amine and 6-benzyloxy-7-(2-[18F]fluoroethyl)-7H-purin-2-yl-amine. Applied Radiation and Isotopes. 56(3). 511–517. 8 indexed citations

20.

Beyer, G.J., et al.. (1992). Simultaneous study of the biodistribution of radio-yttrium complexed with EDTMP and citrate ligands in tumour-bearing rats. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 19(2). 201–203. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact